These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 3677010)
21. Superficial TCC bladder cancer: the impact of tumor differentiation on recurrence, progression and survival. Kurth KH Prog Clin Biol Res; 1984; 162A():307-18. PubMed ID: 6483914 [No Abstract] [Full Text] [Related]
22. The role of combined method in organ-sparing treatment of muscle-invasive bladder cancer recurrences. Startsev VY Arch Ital Urol Androl; 2002 Jun; 74(2):54-6. PubMed ID: 12161935 [TBL] [Abstract][Full Text] [Related]
23. Recurrence and progression of T1G3 transitional cell carcinoma of the bladder treated with intravesical bacillus Calmette-Guérin. Günlüsoy B; Değirmenci T; Arslan M; Nergiz N; Minareci S; Ayder AR Urol Int; 2005; 75(2):107-13. PubMed ID: 16123562 [TBL] [Abstract][Full Text] [Related]
24. [Clinical investigation for recurrence and progression in Ta grades 1 and 2 bladder cancer]. Takei K; Kotake T; Masai M; Ito H; Nagao K; Chiba K; Saito K; Hirokawa M Hinyokika Kiyo; 1997 Mar; 43(3):185-9. PubMed ID: 9127752 [TBL] [Abstract][Full Text] [Related]
25. Prognosis of bladder cancer. I. Risk factors in superficial transitional cell carcinoma. Pagano F; Garbeglio A; Milani C; Bassi P; Pegoraro V Eur Urol; 1987; 13(3):145-9. PubMed ID: 3609087 [TBL] [Abstract][Full Text] [Related]
26. Initial tumor stage and grade as a predictive factor for recurrence in patients with stage T1 grade 3 bladder cancer. Kwak C; Ku JH; Park JY; Lee E; Lee SE; Lee C J Urol; 2004 Jan; 171(1):149-52. PubMed ID: 14665864 [TBL] [Abstract][Full Text] [Related]
27. The predictive value of GSTT1 polymorphisms in predicting the early response to induction BCG therapy in patients with non-muscle invasive bladder cancer. Kang HW; Tchey DU; Yan C; Kim WT; Kim YJ; Yun SJ; Lee SC; Choi YH; Kim IY; Kim WJ Urol Oncol; 2014 May; 32(4):458-65. PubMed ID: 24411789 [TBL] [Abstract][Full Text] [Related]
28. Urachal carcinomas of the nonglandular type: salient features and considerations in pathologic diagnosis. Paner GP; Barkan GA; Mehta V; Sirintrapun SJ; Tsuzuki T; Sebo TJ; Jimenez RE Am J Surg Pathol; 2012 Mar; 36(3):432-42. PubMed ID: 22301493 [TBL] [Abstract][Full Text] [Related]
29. Comparison of 2004 and 1973 World Health Organization grading systems and their relationship to pathologic staging for predicting long-term prognosis in patients with urothelial carcinoma. Cao D; Vollmer RT; Luly J; Jain S; Roytman TM; Ferris CW; Hudson MA Urology; 2010 Sep; 76(3):593-9. PubMed ID: 20381131 [TBL] [Abstract][Full Text] [Related]
30. Studies of transitional cell tumours of the bladder. Prognosis and causes of death. Sjolin KE; Nyholm K; Trautner K Acta Pathol Microbiol Scand A; 1976 Sep; 84(5):361-74. PubMed ID: 970124 [TBL] [Abstract][Full Text] [Related]
31. Histologic grading of urothelial carcinoma: a reappraisal. Cheng L; MacLennan GT; Lopez-Beltran A Hum Pathol; 2012 Dec; 43(12):2097-108. PubMed ID: 22542126 [TBL] [Abstract][Full Text] [Related]
32. The pathologist's role in multidisciplinary management of bladder cancer. Szakacs JE; Pow-Sang J Ann Clin Lab Sci; 1994; 24(6):481-8. PubMed ID: 7847776 [TBL] [Abstract][Full Text] [Related]
33. The nested variant of bladder transitional cell carcinoma: Review of 12 cases and review of the literature. Carrion-Ballardo CJ; Gala-Solana L; Portillo-Martin JA; Azueta-Etxebarria A; Truan-Cacho D; Campos-Juanatey F Actas Urol Esp; 2015; 39(6):387-91. PubMed ID: 25670479 [TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder: a clinicopathologic study of 1,515 cases. Pan CC; Chang YH; Chen KK; Yu HJ; Sun CH; Ho DM Am J Clin Pathol; 2010 May; 133(5):788-95. PubMed ID: 20395527 [TBL] [Abstract][Full Text] [Related]
35. Microstaging of pT1 transitional cell carcinoma of the bladder. Does it really differentiate two populations with different prognoses? (pT1 subcategory). Sözen S; Akbal C; Sökmensüer C; Ekici S; Ozen H Urol Int; 2002; 69(3):200-6. PubMed ID: 12372888 [TBL] [Abstract][Full Text] [Related]
36. The treated histories of patients with Ta grade 1 transitional-cell carcinoma of the bladder. Prout GR; Bassil B; Griffin P Arch Surg; 1986 Dec; 121(12):1463-8. PubMed ID: 3789916 [TBL] [Abstract][Full Text] [Related]
37. Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers. Novara G; De Marco V; Gottardo F; Dalpiaz O; Bouygues V; Galfano A; Martignoni G; Patard JJ; Artibani W; Ficarra V Cancer; 2007 Oct; 110(8):1715-22. PubMed ID: 17724728 [TBL] [Abstract][Full Text] [Related]
39. Transitional cell carcinomas of the urinary bladder. A histopathological study. Ahmed Z; Muzaffer S; Khan M; Kayani N; Pervez S; Husseini AS; Hasan SH J Pak Med Assoc; 2002 Sep; 52(9):396-8. PubMed ID: 12532572 [TBL] [Abstract][Full Text] [Related]